Profits and halos: The role of firm profitability information in consumer inference
β Scribed by Steven S. Posavac; Michal Herzenstein; Frank R. Kardes; Suresh Sundaram
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 701 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1057-7408
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Three experiments investigated the consequences of the presence of information that a manufacturing firm is profitable on consumers' judgments of the firm and the consequences for perceptions of advertising, products, and choice intention. When profitability is present in the advertising context, consumers form more favorable advertiser judgments, which drive perceptions of greater advertisement credibility, which lead to more favorable product inferences, and ultimately stronger purchase intentions. The third experiment additionally shows that profitability information interacts with a warranty to drive judgments and choice. The implication of our findings is that firms should consider highlighting their profitability to enhance advertising effectiveness.
π SIMILAR VOLUMES
This paper estimates the effects of actual and potential rivalry on profitability of firms in the U.S. pharmaceutical industry during the 20-year period 1963-82. The results show that during the 1960s actual rivalry among the sampled firms did not materially affect firm profitability, but that durin
*The Economist: Marketing for Growth* is a guide to how marketing can and should become a business's most important driver of growth. Marketers play a crucial role in generating revenue, and they can play an equally important role in how revenues translate into profit. They can help a company achiev
## Abstract This report analyzes determinants of profitability differences between subsidiaries of Multinational Enterprises (MNEs) and Domestic Enterprises (DMEs) in the Greek food industry using company level data. Previous studies have tested the hypothesis that ownershipβspecific advantages are
## Abstract We introduce a computational model of the evolution of a valueβmaximizing researchβbased pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions, and candidate attrition rates. We use the model to estimate how the probability of surviving and covering